Resources

Launched at the World Humanitarian Summit, the Compact for Young People in Humanitarian Action is a collective commitment of over 50 humanitarian actors to ensure that the priorities of young people are addressed, and that they are informed, consulted, and meaningfully engaged throughout all stages of humanitarian action. The ‘Inter-agency Guidelines for Working with and for Young People in Humanitarian Settings’ was developed to address the gap in humanitarian tools that tend to overlook young people, a specific but broad demographic with interlinked needs across multiple sectors.

In 2018, IPPF endorsed the WHO/UNFPA Call to Action to Attain Universal Health Coverage Through Linked Sexual and Reproductive Health and Rights and HIV Interventions.13 This IMAP statement serves as a reminder of this call to action to ensure all people have access to comprehensive SRH services, including integrated contraceptive and HIV/STI services, provided through primary healthcare.

To download your poster just click on the image and get printing! We would love to see where your poster ends up, whether it's at a march or on your wall, or anywhere else. Please do tag us on social media: we are @ippf_global on Instagram, @ippf on Twitter and @ippfglobal on Facebook.  All posters are A3 in size.                                          

IPPF is committed to the achievement of gender equality because it is a human right, it advances women’s and girls’ empowerment and it is embedded in sexual and reproductive health and rights (SRHR). As such, we are proud to present a gender equality toolkit for Member Associations – download the PDF file below to find out more. 

Since the early 1990s, the evidence has been inconclusive as to whether using hormonal contraception increases women’s risk of acquiring HIV, particularly among progestogen-only injectable users. Observational studies indicated that women using progestogen-only injectable contraceptive methods may be at higher risk of acquiring human immunodeficiency virus (HIV).  The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial finds no link between HIV acquisition and the use of DMPA-IM, progestogen implant, and non-hormonal copper IUD. For more information please see the technical brief on the ECHO trial.  Following the release of the result of the ECHO trial and the WHO latest guidance statement and revised Medical Eligibility Criteria (MEC) for contraceptive use, IPPF developed a follow-up technical brief to support IPPF MAs and frontline service providers’ work regarding the provision of the integrated contraceptive, HIV and other STI programmes to expand access and contraceptive choice. For more information, please see the attached technical brief After the ECHO trial – Expanding access and choice through integrated services, available in English and French.